Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NPEPPS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RPL7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C6orf62 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ELF2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF75D - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAP4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DCLRE1C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CRIM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EIF3I - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
DNAJC11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
STK11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PKP4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RRAGC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
USP36 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ENOX2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EXOC3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RTCA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DNAJC8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ANKH - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on